GPCRs (G-protein-coupled receptors) play key roles in many cellular processes, and malfunction may lead to a range of pathologies, including psychiatric and neurological disorders. It is therefore not surprising that this group of receptors supplies a majority of the targets for pharmaceutical drug development. Despite their importance, the mechanisms that regulate their function and signalling still remain only partially understood. Recently, it has become evident that a subset of GPCRs is not homogeneously distributed in the plasma membrane, but localizes instead to specific membrane microdomains known as lipid rafts. Lipid rafts are characterized by their enrichment in cholesterol and sphingolipids, and have been suggested to serve as platforms for a range of cellular signalling complexes. In the present review, we will be discussing the effects of the lipid raft environment on trafficking, signalling and internalization of raft-associated GPCRs.
Introduction
The large majority of receptors belongs to the GPCR (G-protein-coupled receptor) superfamily, which means that they couple to heterotrimeric G-proteins. Stimuli as diverse as light photons, taste ligands, neurotransmitters and hormones signal through GPCRs [1] . It is therefore not surprising that these receptors represent the third largest family of genes in the human genome, with an estimated 1% of the genome coding for them.
Even though they are functionally diverse, GPCRs share a range of structural features [1] . Apart from their G-protein-binding properties, these include an extracellular receptor domain involved in ligand binding and a cluster of seven transmembrane helical domains linking the extracellular region with the cytoplasmic tail (Figure 1 ). Upon receptor activation, a conformational change is triggered that leads to separation of the associated G-protein into its constituent ␣ and ␤␥ subunits, which then interact with and regulate distinct intracellular second messenger cascades depending upon the type of G-protein involved.
Recent studies have shown that many G-proteins do not diffuse freely at the plasma membrane, but are instead localized to specialized sphingolipidand cholesterol-enriched platforms known as lipid raft domains [2] [3] [4] . Accordingly, a number of GPCRs have also been found to localize to lipid rafts (Table 1) , and we will be discussing examples of GPCRs whose trafficking and/or signalling may be altered by raft localization. First, we will give a brief summary of lipid raft structure and the main methods used to isolate them. For a broader examination of lipid rafts and their role in cell function, the interested reader is referred to some recent more general reviews [5] [6] [7] [8] [9] .
Lipid raft structure
The saturated hydrocarbon chains of sphingolipids allow for tight packaging of sphingolipid and cholesterol molecules in lipid raft domains. This makes rafts more ordered and less fluid than non-raft membranes, which mostly contain unsaturated, and therefore less densely packed, phospholipids. It also gives raft domains a slightly increased membrane thickness compared with non-raft domains. Because of these physical properties, lipid raft domains concentrate a specific subset of membrane proteins, while excluding most others. In addition, the unique lipid environment may also influence the functional properties of its resident proteins directly.
Structurally, two main types of lipid raft can be identified, namely caveolin-free rafts and caveolae, and a number of GPCRs have been identified in these raft types . Caveolae are named after their constituent structural proteins, the caveolins, which give caveolae their distinct morphology. When visualized by electron microscopy, caveolae are identifiable as flask-shaped plasma membrane invaginations that open up towards the extracellular surface [41] . Caveolin-free rafts lack the distinct structural architecture of caveolae. In fact, caveolin-free rafts have a similar curvature to the surrounding non-raft membrane, and are therefore difficult to study by visual means. Most cell types probably contain both caveolae and caveolin-free lipid rafts, while some, such as neurons, contain only caveolin-free rafts [42] .
The reasons why proteins segregate to lipid rafts are not fully understood. Several mechanisms may contribute to raft association, including post-translational modifications, such as GPI (glycosylphosphatidylinositol) anchors and acylation with myristate and/or palmitate. The G-protein G ␣i subunit, for example, needs to be both myristoylated and palmitoylated in order to localize to lipid rafts [43] . Some proteins may also associate with rafts via a direct protein-protein interaction with a raft-resident protein. Examples of GPCRs that are able to interact directly with the lipid raft protein caveolin include the adenosine A 1 receptor [10, 12] , AT 1 (angiotensin II type 1 receptor) [17] , and the ␤ 2 -adrenoceptor [16] . For a few transmembrane proteins, the lengths and amino acid sequences of their membrane-spanning domains, as well as the sequences of their membrane-proximal extracellular domains, have been shown to influence lipid raft association [5] . Although transmembrane domains have been implicated in the lipid raft association of the latent membrane protein 1 of Epstein-Barr virus [44] and the influenza virus neuraminidase [45] , we are unaware at time of writing (July 2004) of any GPCRs where this has been conclusively shown to be the case.
Studying lipid rafts
Lipid rafts, because of their specific lipid composition, are insoluble in cold non-ionic detergents, and this characteristic has been used historically both to define lipid raft domains and to isolate them [5] [6] [7] [8] [9] . Briefly, detergent-dependent raft isolation methods require that detergent-treated cell membranes are loaded to the bottom of a density gradient and centrifuged at high speed. Because of their low buoyant density and detergent-insolubility, lipid rafts will float up the density gradient, away from the bulk of the cellular material. The detergent-soluble proteins will remain in the lower fractions of the gradient, and the detergent-insoluble cytoskeletal components will pellet at the bottom.
Recently, detergent-free methods of raft isolation have gained some popularity, especially for the enrichment of caveolin-containing rafts [5] [6] [7] [8] [9] . These methods mostly replace the non-ionic detergents used during conventional isolation procedures with a high pH sodium carbonate buffer and rigorous homogenization steps to rupture cell membranes. The resulting membrane fragments are separated by virtue of their different buoyant densities by density-gradient centrifugation. Fractions isolated by detergent-free methods elude the definition of rafts as detergent-insoluble, and may differ in their lipid and protein content from fractions isolated using detergent-insolubility criteria [5, 46] . Table 1 GPCRs that associate with lipid rafts. 'Detergent-dependent' and 'detergent-free' refer to the biochemical isolation methods of lipid rafts either using non-ionic detergents or not using detergent respectively; CM and EM refer to co-localization studies of receptors with lipid rafts by confocal microscopy or electron microscopy respectively; n.a., not assessed. Receptor
Methods used to detect
Mechanism of raft Detergent-free [10, 11] , Bound caveolin-3 [10] Variable results: agonist stimulation led to movement out CM [12] , EM [12] and caveolin-1 [12] of [10] or into [11, 12] lipid rafts
Detergent-free [13] Bound caveolin-3 [13] n.a. [17, 19] or had no effect [18] , EM [19] on localization [18] Bradykinin B1
CM [20] Putative caveolin binding n.a. domain [21] Bradykinin B2 CM [20] , detergent-free [18] , Putative caveolin binding Agonist stimulation led to movement into rafts [18] ; detergent-dependent [22] domain [21] internalization via a raft-dependent mechanism [20] Calcium-sensing Detergent-free [23] n.a.
n.a.
CCR5
Detergent-free [25] , Three palmitoylation sites Cyclodextrin treatment led to loss of detergent-dependent [24] in cytoplasmic tail [26] receptor signalling [25] Endothelin A CM [27] , detergentBound caveolin [27, 29] Filipin inhibited agonist-induced endocytosis [28] dependent [29] Endothelin B Detergent-free [30] , Bound caveolin-1 only in Filipin inhibited signalling [29, 30] , agonist stimulation detergent-dependent [29] absence of agonist [29] resulted in movement out of rafts [29] GABA B Detergent-dependent [31, 32] n.a. Decreased signalling in raft-enriched fractions [32] (␥-aminobutyric acid B)
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© 2005 The Biochemical Society Detergent-free [34] n.a. Agonist stimulation led to movement into rafts [34] ; possibly internalization by raft-dependent mechanism [35] Oxytocin Detergent-free [36, 37] Cholesterol-binding Agonist stimulation of raft-associated compared with non -raft receptors may increase or inhibit cell proliferation respectively [36] Serotonin Detergent-free [38] n.a. Reduced agonist response upon cyclodextrin treatment [38] Sphingosine 1-phosphate Detergent-free [39] Bound caveolin 1 [39] Agonist-induced movement into rafts; caveolin
overexpression inhibited receptor function [39] Thyrotropin CM [40] n.a. Receptor moved out of rafts upon stimulation [40] The different methods that exist to isolate lipid raft domains can make it difficult to compare and assess the data obtained, especially when results are contradictory [46, 47] . Even when using only detergent-dependent isolation methods, results can differ depending on the specific isolation procedure, the protein to detergent ratio, and the type of detergent used [48] . Thus, while biochemical isolation procedures are useful tools for the study of lipid rafts, they are best used in combination with other techniques of raft study.
Additional techniques used to study lipid rafts include the microscopic visualization of lipid raft domains. Lipid rafts are thought to be too small and/or dynamic to be resolved by conventional light microscopy. Because caveolae have a distinct morphology, association of proteins with this raft type can be analysed by electron microscopy as long as suitable antibodies are available. Methods do not (yet) exist for detection of caveolin-free rafts by electron microscopy. Indirect methods of visualization by light microscopy are being developed, an example being FRET (fluorescence resonance energy transfer), which yields a fluorescent signal only when a tagged protein of interest is in very close proximity (Ͻ50 nm) to a tagged raft marker, and can thus be inferred to reside in lipid raft domains [47] . An advantage of FRET is that it can be combined with live-imaging techniques, which give an indication of the dynamic behaviour over time of lipid raft domains.
A widely used approach to study the functional implications of raft association is to manipulate the cholesterol content of membranes using tools such as the cholesterol depleting drug methyl-␤-cyclodextrin, or the cholesterolsequestering antibiotic filipin [49] . These treatments lead to the dissociation of proteins from lipid rafts into non-raft membranes and thereby allow for comparison of receptor signalling properties in raft and non-raft domains. While cholesterol depletion is a very useful tool for studying rafts, it does have pleiotropic effects on all membrane areas, and may potentially affect the functional properties of both raft-associated and non-raft proteins [50] . Functional changes observed upon cholesterol depletion are thus not necessarily due to prior raft-association, and additional methods should be employed to ensure that the protein under study does indeed reside in lipid raft domains.
The effects of lipid raft association on receptor function are increasingly being studied without altering membrane properties by removing or mutating known raft-targeting domains in the receptor. As discussed in more detail below, such an approach was used by Wyse et al. [19] to show, without altering cholesterol levels, that caveolae are necessary for trafficking of the AT 1 receptor to the plasma membrane. Of course, this approach requires that the raft-targeting domains are known and that their removal or mutation will not alter additional properties of the protein other than its raft association. 
Lipid rafts and GPCR signalling
Examples of GPCRs whose signalling seems to be affected by raft localization include the CCR5 (chemokine receptor 5), the GnRH (gonadotropinreleasing hormone) receptor and the ␤ 2 -adrenoceptor (CCR5 may also be an example of a receptor that is internalized via lipid rafts [51] ). Cholesterol depletion decreases signalling of CCR5 and the mammalian GnRH receptor, while enhancing signalling of the ␤ 2 -adrenoceptor.
CCR5
The chemokine receptors are a family of GPCRs that mediate immune cell responses to soluble chemoattractants called chemokines. CCR5 has received much attention recently as a co-receptor of CD4 required for HIV entry into host cells.
CCR5 has been shown by detergent-dependent methods [24] and by confocal microscopy [25] to reside in lipid-raft-enriched domains, and this localization may affect receptor signalling. In studies performed by Nguyen and Taub [25] , CCR5s lost their ligand-binding ability in response to cholesterol extraction using hydroxypropyl-␤-cyclodextrin. Cholesterol extraction also led to a loss of receptor signalling, as measured by intracellular calcium mobilization. The majority of bound agonist appeared to be localized to lipid rafts, suggesting that rafts contained the high-affinity CCR5. These results suggest that localization to lipid rafts is a requirement for effective CCR5 signalling.
Raft localization and signalling seem to be enhanced by CCR5 palmitoylation. Three cysteine residues at the boundary between the seventh transmembrane domain and the cytoplasmic tail of the receptor have been shown to be palmitoylated [26, 52] , and palmitoylation-deficient mutants appear to have both a decreased raft-association, as assessed by confocal microscopy [26] , and a decreased coupling to downstream signalling cascades [52] .
Although lipid raft localization appears to be important for endogenous CCR5 signalling, it does not seem necessary for HIV entry into cells. Results obtained by Percherancier et al. [53] suggest that, when CCR5 resided exclusively in non-raft domains, HIV-1 could still efficiently enter into cells. However, even though lipid raft localization of the chemokine receptor was not essential for HIV cell entry, entry did nevertheless depend on a high cholesterol content of the host cell membrane. Depletion of plasma membrane cholesterol by the drug cyclodextrin inhibited HIV-1 cell entry even when the CCR5 and CD4 receptors were not localized to lipid rafts [53] .
It therefore seems that lipid rafts are needed for endogenous agonist signalling of the CCR5, but probably not for HIV-1 entry into T-cells, which depends more on overall membrane cholesterol content.
Mammalian GnRH receptor
GnRH plays a pivotal role in reproductive processes. It is released by the hypothalamus and binds to receptors on the anterior pituitary, thereby stimulating the synthesis and release of LH (luteinizing hormone), and the release of FSH (follicle-stimulating hormone). Agonist-occupied GnRH receptors link Lipid raft association with G-protein-coupled receptors 157 via early second messenger pathways, such as phospholipase C and InsP 3 formation, to MAPK (mitogen-activated protein kinase) signalling. An important MAPK in this context is ERK (extracellular-signal-regulated kinase). Mammalian GnRH receptors are unusual in that the C-terminal cytoplasmic domain is only 1-2 amino acids in length.
Using both detergent and detergent-free isolation methods, Navratil et al. [33] showed that the GnRH receptor constitutively resided in lipid-raftenriched domains isolated from gonadotropin-derived ␣T3-1 cells. This localization was observed both in the presence and absence of agonist. Similarly, the GnRH receptor resided in lipid-raft-enriched fractions from transfected CHO (Chinese-hamster ovary) cells independently of hormone treatment. Interestingly, while CHO cells express caveolin, this caveolae structural protein is absent in ␣T3-1 cells. Thus localization of the GnRH receptor to lipid rafts seemed independent of agonist stimulation, cell type or expression of caveolin.
While raft localization of the GnRH receptor did not change upon agonist treatment, the lipid raft environment was nevertheless required for effective receptor signalling. Results by Navratil et al. [33] showed that stimulation of the raft-localized receptor resulted in an InsP 3 response, leading to agonistdependent ERK phosphorylation and c-fos gene expression. When rafts were disrupted by methyl-␤-cyclodextrin, all of these agonist responses were lost.
Thus, while the GnRH receptors do not seem to change their raft localization in response to agonist stimulation, they do appear to require lipid rafts for effective signalling.
␤-Adrenoceptor
Cardiac ␤ 1 -and ␤ 2 -adrenoceptors mediate the actions of catecholamines, which increase the rate, and force of contractions, of the heart. The ␤ 1 -adrenoceptor is the main receptor that mediates catecholamine actions under normal physiological conditions, while the ␤ 2 -adrenoceptor operates mainly in neonatal ventricles, and in aged and/or failing hearts, where the ␤ 1 receptor is down-regulated. Both ␤ 1 -and ␤ 2 -adrenoceptors have very similar signalling properties, activating a G-protein-dependent pathway of adenylate cyclase stimulation leading to accumulation of cAMP and to PKA (protein kinase A)-dependent protein phosphorylation.
Both the ␤ 1 -and the ␤ 2 -adrenoceptors have been isolated in lipid-raftenriched fractions, although the extent of raft-localization seems to differ between different cell types and developmental stages. ␤ 1 -and ␤ 2 -adrenoceptors were first studied by Schwencke et al. [14] in raft-enriched fractions obtained using detergent-free isolation methods. When overexpressing the receptors in a heterologous cell system, they found that both receptor types were localized almost exclusively to caveolin-enriched domains.
Subsequently, Rybin et al. [15] showed, using two separate detergent-free isolation methods, that only a subfraction of ␤ 1 -adrenoceptor localized to caveolae in rat neonatal myocyte cultures, and neither agonist treatment nor raft disruption greatly influenced the functional behaviour or distribution pattern of the receptor. In contrast, the ␤ 2 -adrenoceptor was located entirely in the caveolae-rich fractions isolated from both neonatal and adult mouse myocytes [15, 16, 54] , and from quiescent fibroblasts [15] . Furthermore, co-immunoprecipitation of the ␤ 2 -adrenoceptor with caveolin-3 from neonatal mouse myocytes implied a direct interaction between the receptor and this structural protein of caveolae. Manipulation of lipid raft domains using the raft-disrupting agents filipin and methyl-␤-cyclodextrin led to increased receptor signalling, as measured by an increased and prolonged myocyte contraction rate [54] , and increased agonist-induced accumulation of the second messenger cAMP [15] respectively. Furthermore, filipin treatment also resulted in a decreased co-immunoprecipitation of the receptor with caveolin-3.
Thus signalling of the ␤ 2 -adrenoceptor appears to be inhibited by lipid raft localization, and is increased when lipid raft domains are disrupted. However, there may be cell-and expression-system-specific differences in ␤ 2 -adrenoceptor partitioning. The receptor seems largely excluded from caveolar membranes in vascular smooth muscle cells [55, 56] . Furthermore, Odley et al. [57] failed to detect human ␤ 2 -adrenoceptor in lipid raft domains isolated from resting-state cardiac myocytes when overexpressed in transgenic mice.
Lipid rafts and GPCR trafficking and internalization
Internalization follows agonist-induced G-protein phosphorylation and contributes to prolonged receptor desensitization. The AT 1 receptor appears to utilize lipid rafts for trafficking, and may internalize via a raft-dependent mechanism. Other GPCRs that seem to be internalized by raft-dependent mechanisms include the adenosine A 1 receptor, the B 2 bradykinin receptor and the chicken GnRH receptor.
AT 1 receptor
Angiotensin II plays a key role in the regulation of cardiovascular homoeostasis by regulating blood volume and vascular resistance. The actions of angiotensin II are mediated by AT 1 and AT 2 (angiotensin II type 2) receptors. The AT 1 receptor is the main angiotensin receptor in adult tissue, and mediates most of the actions of angiotensin II. It acts mainly on phospholipases, phosphoinositides, calcium channels, and serine/threonine and tyrosine kinases.
Ishizaka et al. [17] and Ushio-Fukai et al. [58] showed that the AT 1 receptor was absent from lipid-raft-enriched fractions isolated by detergent-free methods from unstimulated vascular smooth muscle cells, but moved into raftenriched fractions upon agonist activation. In addition, they also identified a consensus binding site for interaction with caveolin in the AT 1 receptor, and were furthermore able to co-immunoprecipitate the AT 1 receptor with caveolin-1 following agonist stimulation. Thus, according to these studies, the AT 1 receptor localizes to caveolae upon agonist activation, where it interacts with caveolin-1.
However, a later publication by Leclerc et al. [18] , who used both detergent-dependent and detergent-free isolation methods, seemed to show that the Lipid raft association with G-protein-coupled receptors 159
proportion of AT 1 receptor in lipid-raft-enriched membrane fractions did not increase upon agonist stimulation, at least not in the heterologously transfected COS cell line used. Interestingly, however, the authors identified a caveolin scaffolding domain binding sequence at the C-terminus of the AT 1 receptor, a mutation of which led to decreased plasma membrane expression and decreased agonist-induced internalization of the receptor [18] . Wyse et al. [19] approached the questions of whether and when the AT 1 receptor resides in lipid rafts using a combination of methods. First, using the detergent-free method to isolate lipid-raft-enriched membrane domains, they showed that stimulation with angiotensin II caused a translocation of the AT 1 receptor to raft-enriched fractions. Secondly, using electron microscopy, they identified agonist-induced receptor clusters in membrane domains that were sensitive to the raft-disrupting drug cyclodextrin. However, these domains lacked the characteristic morphology of caveolae. Furthermore, identified caveolae did not contain AT 1 . Thus the receptor probably resided in caveolinfree lipid raft domains. Surprisingly, in cells lacking caveolin-1 and caveolin-3, the AT 1 receptor failed to travel to the cell surface and remained instead in the endoplasmic reticulum. However, when caveolin-1 or caveolin-3 were ectopically expressed, this allowed for trafficking of the receptor to the plasma membrane. Furthermore, mutation of important residues within the caveolin scaffolding domain binding sequence of the AT 1 receptor similarly confined the receptor to the endoplasmic reticulum even in the presence of the caveolins.
These results suggest that caveolins are necessary for trafficking of the AT 1 receptor to the cell surface. Once at the cell surface, however, the receptor seems to localize to the caveolin-free type of lipid raft. Caveolins thus act as molecular chaperones rather than as plasma membrane scaffolds for the AT 1 receptor.
Adenosine A 1 receptor
The nucleotide adenosine plays an import role in coupling the metabolic rate of cells to their energy supply. To date, four adenosine receptors have been identified, namely A 1 , A 2a , A 2b and A 3 , and all are coupled to G-proteins.
The A 1 adenosine receptor is thought to mediate the effects of adenosine during pathophysiological conditions such as hypoxia. Caveolae have been shown to be enriched in the A 1 adenosine receptor. Reports differ, however, on the extent to which the receptor associates with caveolae in quiescent unstimulated cells, and on whether it moves into or out of rafts upon agonist treatment.
Lasley et al. [10] were the first to report an association of the adenosine A 1 receptor with caveolae. Using non-detergent methods, they isolated approx. two-thirds of the adenosine A 1 receptors in caveolin-enriched membrane fractions from unstimulated cardiac ventricular myocytes. The receptors were found to bind directly to caveolin, with an antibody against caveolin-3 coimmunoprecipitating A 1 adenosine receptors together with caveolin-3. Agonist stimulation resulted in a decrease of receptor in caveolin-enriched fractions. In particular, stimulation with the adenosine analogue CCPA (2-chloro-N 6 -cyclopentyladenosine) in the presence of adenosine deaminase to sequester free adenosine resulted in A 1 receptor translocation from caveolin-enriched into non-caveolin-enriched membrane fractions, an effect that was blocked by a receptor antagonist. These observations suggest that, in vivo in cardiac myocytes, the inactive form of the receptor is located in lipid rafts, and moves into non-raft domains upon activation.
These results contrast with those obtained by Rafael Franco's research group [11, 12] . Using a detergent-free method to enrich for lipid raft-containing membrane fractions from a cultured epithelial cell line, Ginés et al. [11] found that only a very small proportion of A 1 adenosine receptors was present in these fractions in unstimulated cells. Upon agonist treatment, the A 1 adenosine receptor was found to have translocated into caveolin-containing fractions, from where it was seen to be internalized [11, 12] . Caveolin-1 was able to bind a C-terminal domain construct of the A 1 adenosine receptor, thereby indicating a possible in vivo interaction between the full-length receptor and caveolin.
The differences in lipid raft localization and agonist effects found in the above studies may be due to differences in the cell types under study. Different, cell-type-specific distribution patterns between raft and non-raft domains have been observed for other GPCRs, such as the ␤-adrenoceptor (discussed above). However, future studies need to test different agonist doses and exposure times with respect to lipid raft localization in the different cell types in order to determine the kinetics of receptor movement out of and (back) into rafts, and the effects on receptor function, internalization and desensitization. Furthermore, the effects on receptor raft localization of adenosine deaminase, which was included in the myocytes study, need to be determined.
B 1 and B 2 bradykinin receptors
Bradykinin is a vasoactive peptide that acts through the two homologous GPCRs, the bradykinin 1 (B 1 ) receptor and the bradykinin 2 (B 2 ) receptor.
The B 1 bradykinin receptor displays high basal agonist-independent signalling, no ligand-induced phosphorylation, and no internalization upon agonist stimulation. The B 2 receptor, on the other hand, shows ligand-induced phosphorylation, and is internalized upon agonist stimulation. Receptor signalling through G-proteins to phospholipase C leads to phosphoinositide hydrolysis and subsequent intracellular calcium mobilization. Both the B 1 and the B 2 bradykinin receptors have a putative caveolin-binding domain [21] .
Using confocal microscopy of fluorescently tagged proteins, Sabourin et al. [20] showed that the B 1 bradykinin receptor co-localized with caveolin-1 upon agonist treatment, but was not internalized, while the B 2 receptor seemed to internalize via a raft-dependent process upon agonist treatment. Employing detergent and detergent-free biochemical enrichment methods of lipid raft membranes together with electron microscopy analysis, de Weerd and LeebLundberg [22] studied raft-association of the bradykinin B 2 receptor in a smooth muscle cell line. In these cells, the basal amount of receptor in rafts was very low. However, when bradykinin was bound to the B 2 receptor, the receptor and its associated G-proteins were recruited to caveolae. Although bradykinin-induced hydrolysis of phosphoinositides occurred within just a few seconds of receptor stimulation (t 1/2 approx. 15 s), the enrichment of Gproteins in lipid rafts was only observed after several minutes (t 1/2 2-5 min).
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These results suggest that localization to caveolae is not required for early signalling through the B 2 bradykinin receptor. Instead, the time frame of Gprotein enrichment in rafts parallels that of receptor desensitization [59] and internalization, suggesting that lipid rafts are involved in B 2 receptor internalization and possibly sequestration.
Non-mammalian GnRH receptor
As mentioned above, GnRH plays a key role in reproduction and its receptor localizes to lipid raft domains [33] . Interestingly, while the mammalian GnRH receptor displays slow internalization kinetics in response to agonist binding, the chicken GnRH receptor internalizes rapidly in a process that depends on its long C-terminal tail. Long intracellular tails are a common feature of non-mammalian GnRH receptors, but are absent in the mammalian receptors [60] .
Pawson et al. [60] have shown that the fast internalization kinetics of the chicken GnRH receptor depend on caveolae. The fast kinetics were lost upon disruption of caveolae by the drug filipin or by overexpressing a dominantnegative caveolin-1 mutant. Furthermore, internalization was also inhibited when a putative C-terminal membrane-proximal palmitoylation site was mutated out (Cys 328 →Ala). Although the authors did not show direct evidence for palmitoylation at this site, it corresponds to a similar site in the ␤ 2 -adrenoceptor that is palmitoylated [60] . A possible effect of this mutation on raft association was not reported.
These results suggest that the fast internalization kinetics of the chicken GnRH receptor depend on caveolae and possibly on receptor palmitoylation.
Concluding remarks
GPCRs play key roles both in physiological and pathological processes, and lipid rafts provide an important mechanism for modulating some of these functions. Not all GPCRs localize to lipid rafts. Of those that do, most associate in a partial and reversible fashion, thus providing a mechanism for influencing receptor behaviour depending on the membrane localization. The superfamily of GPCRs belongs to one of the largest family of genes in the human genome and is made up of eight evolutionarily unrelated, but convergent families of GPCRs. It is not surprising, therefore, that different lipid raft effects are observed for different GPCRs. Further research may allow us to identify a unifying pattern, such as specific receptor subgroups that associate with and are modulated by lipid rafts in similar ways.
